Jun-fei Gu

Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer

Jialin Meng, Lei Gao, Shenglin Gao, 2020, bioRxiv.

Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC

S. Yeh, Chawnshang Chang, J. Cui, 2020, Cell Death & Disease.

MECOM promotes supporting cell proliferation and differentiation in cochlea

N. Zuo, Jun-fei Gu, Jun-fei Gu, 2021, Journal of otology.